14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.92 $1.42 Tuesday, 23rd Apr 2024 BLUE stock ended at $0.97. This is 1.78% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 10.09% from a day low at $0.95 to a day high of $1.05.
90 days $0.88 $1.92
52 weeks $0.88 $5.53

Historical bluebird bio prices

Date Open High Low Close Volume
Dec 02, 2020 $45.80 $46.70 $45.30 $46.19 1 292 833
Dec 01, 2020 $44.55 $46.15 $44.10 $45.87 768 044
Nov 30, 2020 $44.36 $44.54 $43.34 $44.09 914 296
Nov 27, 2020 $43.56 $44.78 $43.51 $44.06 529 726
Nov 25, 2020 $42.92 $43.50 $42.20 $43.23 613 245
Nov 24, 2020 $43.00 $43.20 $42.19 $42.64 1 397 380
Nov 23, 2020 $43.15 $43.59 $42.63 $42.73 1 166 556
Nov 20, 2020 $44.01 $44.09 $42.65 $43.07 1 532 112
Nov 19, 2020 $44.80 $45.28 $43.77 $44.16 750 891
Nov 18, 2020 $46.50 $46.67 $44.38 $44.43 1 097 643
Nov 17, 2020 $46.18 $46.52 $45.60 $46.36 571 871
Nov 16, 2020 $46.53 $46.87 $45.60 $46.40 625 934
Nov 13, 2020 $45.61 $46.30 $45.31 $46.01 521 197
Nov 12, 2020 $45.37 $46.88 $44.80 $45.41 695 639
Nov 11, 2020 $47.29 $47.29 $44.85 $45.48 929 881
Nov 10, 2020 $46.78 $47.21 $45.07 $46.61 1 158 415
Nov 09, 2020 $47.35 $48.00 $46.17 $46.46 1 219 751
Nov 06, 2020 $48.31 $48.63 $45.25 $45.89 2 508 482
Nov 05, 2020 $48.35 $50.82 $44.83 $48.83 7 510 452
Nov 04, 2020 $55.67 $59.32 $55.35 $58.55 1 010 062
Nov 03, 2020 $53.16 $55.30 $53.16 $54.55 796 632
Nov 02, 2020 $52.47 $55.24 $52.15 $53.09 1 152 581
Oct 30, 2020 $52.83 $53.79 $51.46 $51.71 622 380
Oct 29, 2020 $52.59 $53.59 $51.36 $52.89 738 019
Oct 28, 2020 $53.09 $53.49 $51.72 $52.49 496 207
Click to get the best stock tips daily for free!

About bluebird bio

bluebird bio bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clini... BLUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT